Key Takeaways
- The European Medicines Agency is working to assist drug companies in developing treatments for systemic sclerosis (SSc), a rare autoimmune disorder for which there are no approved treatments.
The European Medicines Agency is exploring how to help drug companies develop treatments for systemic sclerosis (SSc), a rare connective...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?